Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00477139
Status:
COMPLETED
Last Update Posted:
2011-04-13
First Post:
2007-05-18
Brief Title:
A Pilot Study Evaluating the Immunologic Status of Patients With HER2 Breast Cancer
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
A Pilot Study Evaluating the Immunologic Status of Patients With HER2 Breast Cancer
Status:
COMPLETED
Status Verified Date:
2011-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a pilot study to gather preliminary data on the baseline immunologic status of patients with HER-2 breast cancer and to establish an immune monitoring laboratory for future clinical trial
Detailed Description:
This is a pilot study to gather preliminary data on the baseline immunologic status of patients with HER-2 breast cancer and to establish an immune monitoring laboratory for future clinical trial We will ask up to 10 patients with HER-2 breast cancer in stable condition and in reasonable health to participate in this study The study will establish an immune monitoring for correlative studies done in patients with HER-2 breast cancer The immunologic tests that will be done are ELISpot lymphocyte proliferation intracellular cytokine staining lymphocyte immunophenotyping and ELISA
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 97811 | OTHER | None | None |
| BRSADJ0009 | OTHER | Stanford University | None |